| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034160446 |
| P356 | DOI | 10.1007/BF02816102 |
| P698 | PubMed publication ID | 7888102 |
| P2093 | author name string | B Leveugle | |
| H Fillit | |||
| P2860 | cites work | Glycoproteins and proteoglycans of the chromaffin granule matrix | Q70273442 |
| Purification of amyloid-associated heparan sulphate proteoglycans and galactosaminoglycan free chains from human tissues | Q70563229 | ||
| Interactions of asymmetric forms of acetylcholinesterase with basement membrane components | Q71766942 | ||
| Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan | Q24643493 | ||
| The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor | Q29618322 | ||
| Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis | Q30449845 | ||
| In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease | Q33554297 | ||
| Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease | Q33554847 | ||
| Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain | Q33688786 | ||
| Nerve growth factor potentiates the neurotoxicity of beta amyloid | Q33902219 | ||
| Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels | Q33931836 | ||
| Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease | Q34309107 | ||
| Molecular and cellular characterization of the glial roof plate of the spinal cord and optic tectum: a possible role for a proteoglycan in the development of an axon barrier | Q34556986 | ||
| The participation of interleukin-6 in the pathogenesis of alzheimer's disease | Q35155272 | ||
| Cytokines and inflammatory proteins in alzheimer's disease | Q35155275 | ||
| The Involvement of Proteases, Protease Inhibitors, and an Acute Phase Response in Alzheimer's Disease a | Q35186145 | ||
| Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome | Q35811925 | ||
| The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease | Q35819186 | ||
| Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells | Q36152115 | ||
| Aggregates of acetylcholine receptors are associated with plaques of a basal lamina heparan sulfate proteoglycan on the surface of skeletal muscle fibers | Q36208287 | ||
| Extracellular matrix organization in developing muscle: correlation with acetylcholine receptor aggregates | Q36211013 | ||
| Immunocytochemical localization of a chondroitin sulfate proteoglycan in nervous tissue. II. Studies in developing brain | Q36211335 | ||
| A nerve terminal anchorage protein from electric organ | Q36213189 | ||
| Nerve terminal anchorage protein 1 (TAP-1) is a chondroitin sulfate proteoglycan: biochemical and electron microscopic characterization | Q36217067 | ||
| A monoclonal antibody against a laminin-heparan sulfate proteoglycan complex perturbs cranial neural crest migration in vivo | Q36218333 | ||
| Interleukin 1 of the central nervous system is produced by ameboid microglia | Q36352241 | ||
| Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact | Q36416236 | ||
| A dual receptor system is required for basic fibroblast growth factor activity | Q36428185 | ||
| The primary structure of NG2, a novel membrane-spanning proteoglycan | Q36530061 | ||
| A large chondroitin sulfate proteoglycan has the characteristics of a general extracellular matrix component of adult brain | Q36694983 | ||
| Functions and mechanisms of interleukin 1 in the brain | Q36983479 | ||
| Proteoglycans: structures and interactions | Q37285263 | ||
| Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? | Q37354483 | ||
| Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes | Q37671601 | ||
| Nervous tissue proteoglycans | Q38235074 | ||
| Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses | Q38715604 | ||
| Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease | Q39100250 | ||
| A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth | Q39101259 | ||
| Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro | Q39101918 | ||
| Sulfated glycosaminoglycans: a common constituent of all amyloids? | Q39102610 | ||
| Sulfated glycosaminoglycans in Alzheimer's disease | Q39104949 | ||
| Elevated circulating tumor necrosis factor levels in Alzheimer's disease | Q41145103 | ||
| Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells | Q41164405 | ||
| Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans | Q41481255 | ||
| A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. | Q41499345 | ||
| A muscle cell variant defective in glycosaminoglycan biosynthesis forms nerve-induced but not spontaneous clusters of the acetylcholine receptor and the 43 kDa protein. | Q41576860 | ||
| Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. | Q41596979 | ||
| Production of the Alzheimer amyloid beta protein by normal proteolytic processing | Q41599298 | ||
| Amyloid beta-peptide is produced by cultured cells during normal metabolism | Q41602809 | ||
| Retinoic acid induced differentiated neuroblastoma cells show increased expression of the beta A4 amyloid gene of Alzheimer's disease and an altered splicing pattern | Q41722059 | ||
| The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion | Q41760569 | ||
| The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis | Q41838706 | ||
| Cleavage of amyloid beta peptide during constitutive processing of its precursor | Q41852594 | ||
| Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease | Q42016311 | ||
| Circular-dichroism studies on two murine serum amyloid A proteins | Q42163690 | ||
| Regulation of Nerve Growth Factor (NGF) Synthesis in the Rat Central Nervous System: Comparison between the Effects of Interleukin-1 and Various Growth Factors in Astrocyte Cultures and in vivo | Q42523364 | ||
| Glycosaminoglycans and glycoproteins associated with rat brain nuclei | Q44015695 | ||
| Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease | Q44627473 | ||
| Microglia in cerebellar plaques in Alzheimer's disease | Q44763168 | ||
| Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing | Q45039717 | ||
| Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease | Q46088641 | ||
| Presence and role of glycosaminoglycans in amyloidosis | Q46257962 | ||
| Neuroimmunology of Alzheimer's disease: a conference report | Q46675608 | ||
| Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease | Q46691404 | ||
| Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease | Q46852742 | ||
| Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease | Q47208290 | ||
| The high molecular weight Cat-301 chondroitin sulfate proteoglycan from brain is related to the large aggregating proteoglycan from cartilage, aggrecan | Q47412060 | ||
| Heparin-polypeptide interactions in aqueous solution | Q47904557 | ||
| Isolation and properties of a soluble chondroitin sulfate proteoglycan from brain | Q47967508 | ||
| Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells | Q48309414 | ||
| Developmental change in the glycosaminoglycan composition of the rat brain | Q48317350 | ||
| Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. | Q48345261 | ||
| The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth | Q48458288 | ||
| Isolation and characterization of the heparan sulfate proteoglycans of brain. Use of affinity chromatography on lipoprotein lipase-agarose. | Q48496456 | ||
| Glycosaminoglycans of rat cerebellum: II. A developmental study | Q48514038 | ||
| Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of brain identified with monoclonal antibodies. | Q48674460 | ||
| CHEMICAL STUDIES ON ALZHEIMER'S DISEASE | Q51253300 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| Characterization of proteoglycans in Alzheimer's disease fibroblasts. | Q52231479 | ||
| Developmental and age-related changes in rat brain glycosaminoglycans. | Q52249761 | ||
| Occurrence of three distinct molecular species of chondroitin sulfate proteoglycan in the developing rat brain. | Q52250936 | ||
| Molecular modeling of protein-glycosaminoglycan interactions. | Q52546742 | ||
| Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions | Q53179441 | ||
| Morphological differentiation and proteoglycan synthesis regulate Alzheimer amyloid precursor protein processing in PC-12 and human astrocyte cultures | Q53179452 | ||
| Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. | Q53180704 | ||
| Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. | Q53186634 | ||
| Focusing on IL-1-promotion of beta-amyloid precursor protein synthesis as an early event in Alzheimer's disease. | Q53187021 | ||
| Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. | Q53187594 | ||
| Theme and variations on a string of amyloid. | Q53189409 | ||
| Are heparan sulphate (HS) sulphotransferases implicated in the pathogenesis of Alzheimer's disease? | Q53209567 | ||
| Neuronal cell–cell adhesion depends on interactions of N-CAM with heparin-like molecules | Q59070399 | ||
| Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve | Q59086360 | ||
| Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells | Q62699021 | ||
| Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition | Q67976646 | ||
| Peanut agglutinin and chondroitin-6-sulfate are molecular markers for tissues that act as barriers to axon advance in the avian embryo | Q67996212 | ||
| Heparan sulfate proteoglycans in amyloidogenesis: an epiphenomenon, a unique factor, or the tip of a more fundamental process? | Q68591475 | ||
| Heparin protects basic and acidic FGF from inactivation | Q68895706 | ||
| Structural properties of the heparan sulfate proteoglycans of brain | Q69294202 | ||
| A special type of senile plaque, possibly an initial stage | Q69435916 | ||
| Heparin modulation of the neurotropic effects of acidic and basic fibroblast growth factors and nerve growth factor on PC12 cells | Q70175497 | ||
| P433 | issue | 1-3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 25-32 | |
| P577 | publication date | 1994-08-01 | |
| P1433 | published in | Molecular Neurobiology | Q15716645 |
| P1476 | title | Proteoglycans and the acute-phase response in Alzheimer's disease brain | |
| P478 | volume | 9 |
| Q24292273 | Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells |
| Q26776157 | Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment |
| Q35215412 | Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit |
| Q34386113 | Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q58283024 | Proteoglycans and the extracellular matrix in amyloidosis |
| Q51935815 | Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease. |
| Q36483870 | Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease |
| Q48581408 | The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. |
Search more.